| Literature DB >> 28783671 |
LaTonya D Williams1, Gilad Ofek2, Sebastian Schätzle3, Jonathan R McDaniel3, Xiaozhi Lu1, Nathan I Nicely1, Liming Wu2, Caleb S Lougheed2, Todd Bradley1,4, Mark K Louder5, Krisha McKee5, Robert T Bailer5, Sijy O'Dell5, Ivelin S Georgiev6, Michael S Seaman7, Robert J Parks1, Dawn J Marshall1, Kara Anasti1, Guang Yang1, Xiaoyan Nie1, Nancy L Tumba8,9, Kevin Wiehe1,4, Kshitij Wagh10, Bette Korber10, Thomas B Kepler11, S Munir Alam1,4,12, Lynn Morris8,9, Gift Kamanga13, Myron S Cohen14, Mattia Bonsignori1,4, Shi-Mao Xia1, David C Montefiori1,15, Garnett Kelsoe1,16, Feng Gao1,4, John R Mascola5, M Anthony Moody1,16,17, Kevin O Saunders1,15, Hua-Xin Liao1,4, Georgia D Tomaras1,15,16,18, George Georgiou19,20, Barton F Haynes21,4,16.
Abstract
Induction of broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development. Antibody 10E8, reactive with the distal portion of the membrane-proximal external region (MPER) of HIV-1 gp41, is broadly neutralizing. However, the ontogeny of distal MPER antibodies and the relationship of memory B cell to plasma bnAbs are poorly understood. HIV-1-specific memory B cell flow sorting and proteomic identification of anti-MPER plasma antibodies from an HIV-1-infected individual were used to isolate broadly neutralizing distal MPER bnAbs of the same B cell clonal lineage. Structural analysis demonstrated that antibodies from memory B cells and plasma recognized the envelope gp41 bnAb epitope in a distinct orientation compared with other distal MPER bnAbs. The unmutated common ancestor of this distal MPER bnAb was autoreactive, suggesting lineage immune tolerance control. Construction of chimeric antibodies of memory B cell and plasma antibodies yielded a bnAb that potently neutralized most HIV-1 strains.Entities:
Year: 2017 PMID: 28783671 PMCID: PMC5905719 DOI: 10.1126/sciimmunol.aal2200
Source DB: PubMed Journal: Sci Immunol ISSN: 2470-9468